drugset / Trial / NCT03932864
Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor
RandomizedSequentialQuadruple-blindTreatment
Summary
To investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MGTA-145 in healthy volunteers as a single agent and in combination with plerixafor.
Timeline
- Start
- 2019-04-22
- Primary completion
- 2020-02-25
- Completion
- 2020-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MGTA-145 | Protein / enzyme biologic | — | Intravenous |
| Subject | Plerixafor | Small molecule | 240 ug/kg | Subcutaneous |
Indications
No indication recorded.